tetano
Editor, Senior Moderator
Sci Adv
. 2026 Jan 16;12(3):eaeb0769.
doi: 10.1126/sciadv.aeb0769. Epub 2026 Jan 16.
Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main protease
Sarah N Zvornicanin[SUP] 1 [/SUP], Ala M Shaqra[SUP] 1 [/SUP], Julia Flynn[SUP] 1 [/SUP], Lauren E Intravaia[SUP] 1 [/SUP], Heidi Carias Martinez[SUP] 2 [/SUP], Weiping Jia[SUP] 2 [/SUP], Devendra Kumar Gupta[SUP] 2 [/SUP], Stephanie Moquin[SUP] 2 [/SUP], Dustin Dovala[SUP] 2 [/SUP], Daniel N Bolon[SUP] 1 [/SUP], Brian A Kelch[SUP] 1 [/SUP], Celia A Schiffer[SUP] 1 [/SUP], Nese Kurt Yilmaz[SUP] 1 [/SUP]
Affiliations
The coronaviral main protease (M[SUP]pro[/SUP]) has been the subject of various biochemical and structural studies and a drug target against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. SARS-CoV-2 M[SUP]pro[/SUP] is active as a dimer, but despite apparent cooperativity in catalytic activity, how the two distal active sites communicate and modulate binding and/or catalysis is unclear. Here, we have investigated the interplay between cooperativity, dimerization, and substrate cleavage in SARS-CoV-2 M[SUP]pro[/SUP] through a combination of enzymatic assays, crystal structures, and protein characterization. To disentangle the contribution of each active site to the observed enzymatic activity, we developed a cleavage assay involving heterodimers of active and inactive (catalytic residue mutated or inhibitor-bound) monomers. Notably, we found that heterodimerization increased cleavage efficiency per active monomer. In addition, we mapped a network of critical residues bridging the two active sites and probed this network through engineered mutations. By dissecting the cooperativity and communication between the active sites, we provide insights into the M[SUP]pro[/SUP] reaction cycle and functional significance of its dimeric architecture.
. 2026 Jan 16;12(3):eaeb0769.
doi: 10.1126/sciadv.aeb0769. Epub 2026 Jan 16.
Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main protease
Sarah N Zvornicanin[SUP] 1 [/SUP], Ala M Shaqra[SUP] 1 [/SUP], Julia Flynn[SUP] 1 [/SUP], Lauren E Intravaia[SUP] 1 [/SUP], Heidi Carias Martinez[SUP] 2 [/SUP], Weiping Jia[SUP] 2 [/SUP], Devendra Kumar Gupta[SUP] 2 [/SUP], Stephanie Moquin[SUP] 2 [/SUP], Dustin Dovala[SUP] 2 [/SUP], Daniel N Bolon[SUP] 1 [/SUP], Brian A Kelch[SUP] 1 [/SUP], Celia A Schiffer[SUP] 1 [/SUP], Nese Kurt Yilmaz[SUP] 1 [/SUP]
Affiliations
- PMID: 41544157
- PMCID: PMC12810614
- DOI: 10.1126/sciadv.aeb0769
The coronaviral main protease (M[SUP]pro[/SUP]) has been the subject of various biochemical and structural studies and a drug target against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. SARS-CoV-2 M[SUP]pro[/SUP] is active as a dimer, but despite apparent cooperativity in catalytic activity, how the two distal active sites communicate and modulate binding and/or catalysis is unclear. Here, we have investigated the interplay between cooperativity, dimerization, and substrate cleavage in SARS-CoV-2 M[SUP]pro[/SUP] through a combination of enzymatic assays, crystal structures, and protein characterization. To disentangle the contribution of each active site to the observed enzymatic activity, we developed a cleavage assay involving heterodimers of active and inactive (catalytic residue mutated or inhibitor-bound) monomers. Notably, we found that heterodimerization increased cleavage efficiency per active monomer. In addition, we mapped a network of critical residues bridging the two active sites and probed this network through engineered mutations. By dissecting the cooperativity and communication between the active sites, we provide insights into the M[SUP]pro[/SUP] reaction cycle and functional significance of its dimeric architecture.